Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Department of Internal Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
J Chin Med Assoc. 2020 Jul;83(7):628-633. doi: 10.1097/JCMA.0000000000000356.
A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic.
一种新型传染病，即 2019 年冠状病毒病（COVID-19），自 2019 年 12 月以来在全球范围内传播。由于没有有效的治疗和疫苗，因此控制这种疾病的策略仅为保持社交距离、保持个人卫生、隔离和检疫。然而，所有血液透析患者都需要每周三次治疗。除了终末期肾病（ESRD）患者的集群感染和免疫受损的高风险外，不典型的疾病表现也可能使医疗机构在 COVID-19 大流行期间忽略这些患者。为了避免透析患者之间的 COVID-19 传播，世界各地的主要肾脏病学会分别为筛查、透析设施调整和健康教育提供了指南。在这篇综述中，我们总结了这些指南的主要内容和差异，并解决了 ESRD 患者的即时管理问题，以降低 COVID-19 大流行期间的感染风险。
